OBJECTIVES: Physical exercise may modulate neuropathology and symptoms of Alzheimer's disease (AD). This pilot study assessed the feasibility of conducting a study of moderate-to-high intensity aerobic exercise in home-dwelling patients with mild AD. METHODS: An uncontrolled preintervention-postintervention test design with a single group receiving the same intervention. A total of eight patients with mild to moderate AD from the Copenhagen Memory clinic were included in the study. The intervention lasted for 14 weeks and consisted of supervised, 1-h sessions of aerobic exercise three times per week (50-60% of heart rate reserve for a two-week adaptation period and 70-80 % of heart rate reserve for the remaining 12 weeks) Feasibility was assessed based on acceptability, including attendance and drop-out, safety, and patients' and caregivers' attitudes towards the intervention as well as other relevant parameters. RESULTS: Attendance (mean, range: 90 %, 70-100 %) and retention (seven out of eight) rates were very high. No serious adverse events were observed. In general, patients and caregivers were positive towards the intervention. CONCLUSION: This study shows that it is feasible to conduct moderate-to-high intensity aerobic exercise in community-dwelling patients with mild AD. Our findings indicate that aspects such as a longer adaptation period, information about injury prevention, and need for involvement and support from caregivers should be addressed when planning an exercise intervention in an AD population.
OBJECTIVES: Physical exercise may modulate neuropathology and symptoms of Alzheimer's disease (AD). This pilot study assessed the feasibility of conducting a study of moderate-to-high intensity aerobic exercise in home-dwelling patients with mild AD. METHODS: An uncontrolled preintervention-postintervention test design with a single group receiving the same intervention. A total of eight patients with mild to moderate AD from the Copenhagen Memory clinic were included in the study. The intervention lasted for 14 weeks and consisted of supervised, 1-h sessions of aerobic exercise three times per week (50-60% of heart rate reserve for a two-week adaptation period and 70-80 % of heart rate reserve for the remaining 12 weeks) Feasibility was assessed based on acceptability, including attendance and drop-out, safety, and patients' and caregivers' attitudes towards the intervention as well as other relevant parameters. RESULTS: Attendance (mean, range: 90 %, 70-100 %) and retention (seven out of eight) rates were very high. No serious adverse events were observed. In general, patients and caregivers were positive towards the intervention. CONCLUSION: This study shows that it is feasible to conduct moderate-to-high intensity aerobic exercise in community-dwelling patients with mild AD. Our findings indicate that aspects such as a longer adaptation period, information about injury prevention, and need for involvement and support from caregivers should be addressed when planning an exercise intervention in an AD population.
Authors: Lauren T Ptomey; Eric D Vidoni; Esteban Montenegro-Montenegro; Michael A Thompson; Joseph R Sherman; Anna M Gorczyca; Jerry L Greene; Richard A Washburn; Joseph E Donnelly Journal: J Aging Phys Act Date: 2019-09-01 Impact factor: 1.961
Authors: Lauren T Ptomey; Amanda N Szabo-Reed; Eric D Vidoni; Richard A Washburn; Anna M Gorczyca; Todd D Little; Jaehoon Lee; Brian C Helsel; Kristine N Williams; Joseph E Donnelly Journal: Contemp Clin Trials Date: 2020-09-23 Impact factor: 2.226
Authors: Veronika van der Wardt; Jennie Hancox; Dawid Gondek; Pip Logan; Roshan das Nair; Kristian Pollock; Rowan Harwood Journal: Prev Med Rep Date: 2017-05-18
Authors: Kristian S Frederiksen; Karine Madsen; Birgitte B Andersen; Nina Beyer; Ellen Garde; Peter Høgh; Gunhild Waldemar; Steen G Hasselbalch; Ian Law Journal: Alzheimers Dement (N Y) Date: 2019-06-07
Authors: Francesca Pistollato; Elan L Ohayon; Ann Lam; Gillian R Langley; Thomas J Novak; David Pamies; George Perry; Eugenia Trushina; Robin S B Williams; Alex E Roher; Thomas Hartung; Stevan Harnad; Neal Barnard; Martha Clare Morris; Mei-Chun Lai; Ryan Merkley; P Charukeshi Chandrasekera Journal: Oncotarget Date: 2016-06-28